Patents Assigned to Scottsdale Healthcare Corporation
  • Therapeutic targets for adrenocortical carcinoma
    Patent number: 9222138
    Abstract: This invention identifies and provides a recurrent translocation t(4;8) (p16.2; p23.1) associated with Adrenocortical Carcinoma, and diagnostic methods using the translocation by FISH hybridization or PCR based assays.
    Type: Grant
    Filed: October 1, 2012
    Date of Patent: December 29, 2015
    Assignees: THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE, SCOTTSDALE HEALTHCARE CORPORATION
    Inventors: Kimberly Bussey, Michael J. Demeure
  • Methods of assessing a risk of cancer progression
    Patent number: 8911940
    Abstract: Methods and kits that use miRNA expression to predict the development of brain metastases in non-small cell lung cancer patients are disclosed.
    Type: Grant
    Filed: July 29, 2010
    Date of Patent: December 16, 2014
    Assignees: The Translational Genomics Research Institute, Scottsdale Healthcare Corporation
    Inventors: Glen Weiss, Seungchan Kim, Sara Nasser